The Intergovernmental Authority on Development (IGAD) today opened a two-day workshop to validate the IGAD HIV, tuberculosis and malaria strategic plan for 2018-2025 in Addis Ababa, Ethiopia.
The objective of this meeting, which is bringing together officials from ministries of health and government agencies in charge of refugee affairs at IGAD Member States level, is to validate the strategy to be endorsed during the IGAD health ministerial meeting on regional and cross-border health programs to be held at the same venue on 19th March.
It will also serve to guide improving health services, particularly in HIV, tuberculosis, and malaria, for the refugees in the region, according to a press release issued by IGAD secretariat.
“The purpose of this strategic plan is to complement the national strategic plans of the member states regarding the three diseases,” Acting Director of Health and Social Development of IGAD, Fathia Alwan said in her opening remarks.
“The focus of the IGAD Strategic Plan, however, is on cross-border and mobile populations which have gained more attention in the recent years”, she added.
According to her, the development of the strategic plan 2018-2025 has been participatory, and all stakeholders have been engaged during the process which started in April 2017 “by a brainstorming session on identification of focus areas for the strategic plan”.
USAID Kenya and East Africa Office Deputy Director, Mrs. Wairimu Gakuo, highlighted the support provided by the US government to the Global Fund towards such endeavors, and also the good quality partnership between USAID and IGAD in various areas of intervention.